<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02357134</url>
  </required_header>
  <id_info>
    <org_study_id>2014-0971</org_study_id>
    <secondary_id>NCI-2015-00418</secondary_id>
    <secondary_id>2014-0971</secondary_id>
    <nct_id>NCT02357134</nct_id>
  </id_info>
  <brief_title>High-Flow Oxygen in Reducing Shortness of Breath Caused by Exercise in Patients With Cancer</brief_title>
  <official_title>High-Flow Oxygen for Exertional Dyspnea in Cancer Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>M.D. Anderson Cancer Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Cancer Institute (NCI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>M.D. Anderson Cancer Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This randomized phase II trial studies how well high-flow oxygen works in reducing difficulty&#xD;
      breathing during exercise (exertional dyspnea) in patients with cancer. Dyspnea is linked to&#xD;
      decreased lung function, quality of life, and survival. High-flow oxygen is a device that&#xD;
      delivers heated and humidified oxygen through the nose. This may be effective in reducing&#xD;
      dyspnea, and may help patients' lungs function better and improve their quality of life.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      PRIMARY OBJECTIVES:&#xD;
&#xD;
      I. Obtain preliminary estimates of the effect size of oxygen and high flow rate on exertional&#xD;
      dyspnea (modified Borg Scale adjusted for work rate and baseline dyspnea).&#xD;
&#xD;
      SECONDARY OBJECTIVES:&#xD;
&#xD;
      I. Determine the completion rate of a randomized controlled trial of exertional dyspnea in&#xD;
      cancer patients.&#xD;
&#xD;
      II. Obtain preliminary estimates of the effects of oxygen and flow rate on physiologic&#xD;
      function (respiratory rate and oxygen saturation) and exercise capacity (work rate and&#xD;
      exercise duration).&#xD;
&#xD;
      OUTLINE: All patients undergo a baseline structured exercise session with air. Patients are&#xD;
      then randomized to 1 of 4 treatments for a second session approximately 3 days later.&#xD;
&#xD;
      ARM I: Patients receive high-flow oxygen via nasal prongs during a structured stationary&#xD;
      bicycle exercise session.&#xD;
&#xD;
      ARM II: Patients receive high-flow air via nasal prongs during a structured stationary&#xD;
      bicycle exercise session.&#xD;
&#xD;
      ARM III: Patients receive low-flow oxygen via a nasal cannula during a structured stationary&#xD;
      bicycle exercise session.&#xD;
&#xD;
      ARM IV: Patients receive low-flow air via a nasal cannula during structured stationary&#xD;
      bicycle exercise session.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">March 17, 2015</start_date>
  <completion_date type="Anticipated">May 31, 2021</completion_date>
  <primary_completion_date type="Actual">December 30, 2020</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Modified Borg Scale Dyspnea Intensity at Isotime</measure>
    <time_frame>End of second exercise test and end of third exercise test, approximately up to 12 minutes</time_frame>
    <description>Assessed Dyspnea using the Modified Borg Scale Dyspnea Intensity that ranges from 0 (&quot;no shortness of breath&quot;) to 10 (&quot;worst possible shortness of breath&quot;) at Isotime. Measured the mean difference of Modified Borg Scale Dyspnea Intensity at isotime between the second exercise test (in which all patients received Low Flow Oxygen) and the third exercise tests (in which all patients received the assigned intervention).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Slope of Modified Borg Scale Dyspnea Unpleasantness Over Time During Constant Work Exercise Per Minute (Third Test)</measure>
    <time_frame>Third exercise test, approximately up to 12 minutes</time_frame>
    <description>Dyspnea unpleasantness was measured using the Modified Borg Scale Dyspnea Intensity that ranges from 0 (&quot;no shortness of breath&quot;) to 10 (&quot;worst possible shortness of breath&quot;). Dyspnea intensity was measured every minute. The number of minutes varied by patient, per test. It was measured as pairwise difference of slope (taking 'low flow air' arm as a reference). This linear mixed model was constructed based on the following: Dyspnea Unpleasantness at third test = Minutes + Study Arm + Study Arm*Minutes + Total work rate + Slope of Dyspnea Unpleasantness and Minutes at Second test + Minutes at second test.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Modified Borg Scale Leg Discomfort</measure>
    <time_frame>Third exercise test, approximately up to 12 minutes</time_frame>
    <description>Leg discomfort was measured using the Modified Borg Scale Leg discomfort that ranges from 0 (&quot;no discomfort&quot;) to 10 (&quot;worst possible discomfort&quot;) during the constant work exercise of third test. Leg discomfort was measured every minute. The number of minutes varied by patient, per test. It was measured as pairwise difference of slope (taking 'low flow air' arm as a reference). This linear mixed model was constructed based on the following: Leg Discomfort at third test = Minutes + Study Arm + Study Arm*Minutes + Total work rate + Slope of Leg Discomfort and Minutes at Second test + Minutes at Second test.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Exercise Endurance</measure>
    <time_frame>End of third exercise test, approximately up to 12 minutes</time_frame>
    <description>The Exercise endurance was measured as a mean duration of constant work in minutes during third test. It was measured as pairwise comparison of mean difference of exercise duration (taking 'low flow air' as a reference). This linear mixed model was constructed based on the following: Time at third test = Study Arm + Minutes at Second test. Detail output from the mixed models</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse Events</measure>
    <time_frame>Before and after 3rd test during intervention phase, approximately up to 12 minutes</time_frame>
    <description>Adverse effects related to supplemental oxygen use were assessed using a numeric rating scale from 0 (not at all) to 10 (worst possible) before and after the study intervention. The mean change was measured before and after the 3rd test ranging between -10 (improvement) and +10 (deterioration).</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">74</enrollment>
  <condition>Dyspnea</condition>
  <condition>Malignant Neoplasm</condition>
  <arm_group>
    <arm_group_label>Arm I (high-flow oxygen)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients receive high-flow oxygen via nasal prongs during a structured stationary bicycle exercise session.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm II (high-flow air)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients receive high-flow air via nasal prongs during a structured stationary bicycle exercise session</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm III (low-flow oxygen)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients receive low-flow oxygen via a nasal cannula during a structured stationary bicycle exercise session.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm IV (low-flow air)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients receive low-flow air via a nasal cannula during a structured stationary bicycle exercise session.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Oxygen Therapy</intervention_name>
    <description>Receive high-flow oxygen</description>
    <arm_group_label>Arm I (high-flow oxygen)</arm_group_label>
    <other_name>supplemental oxygen therapy</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Oxygen Therapy</intervention_name>
    <description>Receive high-flow air</description>
    <arm_group_label>Arm II (high-flow air)</arm_group_label>
    <other_name>supplemental oxygen therapy</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Quality-of-Life Assessment</intervention_name>
    <description>Ancillary studies</description>
    <arm_group_label>Arm I (high-flow oxygen)</arm_group_label>
    <arm_group_label>Arm II (high-flow air)</arm_group_label>
    <arm_group_label>Arm III (low-flow oxygen)</arm_group_label>
    <arm_group_label>Arm IV (low-flow air)</arm_group_label>
    <other_name>Quality of Life Assessment</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Questionnaire Administration</intervention_name>
    <description>Ancillary studies</description>
    <arm_group_label>Arm I (high-flow oxygen)</arm_group_label>
    <arm_group_label>Arm II (high-flow air)</arm_group_label>
    <arm_group_label>Arm III (low-flow oxygen)</arm_group_label>
    <arm_group_label>Arm IV (low-flow air)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Respiratory Therapy</intervention_name>
    <description>Receive low-flow oxygen</description>
    <arm_group_label>Arm III (low-flow oxygen)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Respiratory Therapy</intervention_name>
    <description>Receive low-flow air</description>
    <arm_group_label>Arm IV (low-flow air)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Diagnosis of cancer, with evidence of primary or secondary lung involvement&#xD;
&#xD;
          -  Average dyspnea Borg Scale &gt;= 4 of 10 with severe exertion over the past week&#xD;
&#xD;
          -  Oxygen saturation &gt; 90% on ambient air at time of assessment&#xD;
&#xD;
          -  Able to communicate in English or Spanish&#xD;
&#xD;
          -  Karnofsky performance status &gt;= 50%&#xD;
&#xD;
          -  Seen at Supportive Care, cardiopulmonary center, thoracic radiation oncology or&#xD;
             thoracic medical oncology&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Resting dyspnea modified Borg Scale &gt; 7 of 10 at enrollment&#xD;
&#xD;
          -  Severe obstructive lung disease (forced expiratory volume in 1 second [FEV1]/forced&#xD;
             vital capacity [FVC] &lt; 70% post bronchodilator and forced expiratory volume in 1&#xD;
             second &lt; 30% predicted)&#xD;
&#xD;
          -  Delirium (i.e., Memorial Delirium Rating Scale &gt; 13)&#xD;
&#xD;
          -  History of unstable angina or myocardial infarction in the last week&#xD;
&#xD;
          -  Acute pulmonary embolus or pulmonary infarction in the last week&#xD;
&#xD;
          -  Thrombosis of lower extremities in the last week&#xD;
&#xD;
          -  Acute myocarditis, pericarditis, or endocarditis in the last week&#xD;
&#xD;
          -  Symptomatic aortic stenosis or syncope in the last week&#xD;
&#xD;
          -  Suspected dissecting aneurysm&#xD;
&#xD;
          -  Severe untreated resting arterial hypertension (&gt; 200 mmHg systolic, &gt; 120 mmHg&#xD;
             diastolic) at the time of enrollment&#xD;
&#xD;
          -  Uncontrolled arrhythmias causing symptoms or hemodynamic compromise in the last week&#xD;
&#xD;
          -  Uncontrolled heart failure in the last week&#xD;
&#xD;
          -  Pleural effusion requiring thoracentesis within 1 week of study enrollment or&#xD;
             scheduled during the study period&#xD;
&#xD;
          -  Airway obstruction requiring stenting within 1 week of study enrollment or scheduled&#xD;
             during the study period&#xD;
&#xD;
          -  Pneumonia requiring antibiotics at the time of study enrollment&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David Hui</last_name>
    <role>Principal Investigator</role>
    <affiliation>M.D. Anderson Cancer Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>M D Anderson Cancer Center</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.mdanderson.org</url>
    <description>MD Anderson Cancer Center Website</description>
  </link>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>January 29, 2015</study_first_submitted>
  <study_first_submitted_qc>February 5, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 6, 2015</study_first_posted>
  <results_first_submitted>February 18, 2021</results_first_submitted>
  <results_first_submitted_qc>May 27, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">June 1, 2021</results_first_posted>
  <last_update_submitted>May 27, 2021</last_update_submitted>
  <last_update_submitted_qc>May 27, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neoplasms</mesh_term>
    <mesh_term>Dyspnea</mesh_term>
  </condition_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>September 17, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/34/NCT02357134/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Patients were recruited from the Supportive Care, Thoracic Radiation Oncology and Thoracic Medical Oncology clinics at MD Anderson Cancer Center, Houston, USA between 3/2015 and 4/2018 .</recruitment_details>
      <pre_assignment_details>A total of 74 participants were enrolled but 45 patients were randomized for this study. 29 patients were not randomized for various reasons (became ineligible or too symptomatic to participate while waiting=14, scheduling conflict=9, exertional dyspnea too low=4, could not complete baseline test due to desaturation=1, hypertension during exercise=1)</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>High Flow Oxygen</title>
          <description>High Flow Oxygen were delivered between 20 and 70 L/min.</description>
        </group>
        <group group_id="P2">
          <title>High Flow Air</title>
          <description>High Flow Air were delivered between 20 and 70 L/min.</description>
        </group>
        <group group_id="P3">
          <title>Low Flow Oxygen</title>
          <description>Low Flow Oxygen were delivered at 2 L/min.</description>
        </group>
        <group group_id="P4">
          <title>Low Flow Air</title>
          <description>Low Flow Air were delivered at 2 L/min</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="11"/>
                <participants group_id="P2" count="11"/>
                <participants group_id="P3" count="12"/>
                <participants group_id="P4" count="11"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
                <participants group_id="P2" count="11"/>
                <participants group_id="P3" count="12"/>
                <participants group_id="P4" count="11"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>The data is provided for 44 participants who completed the study.</population>
      <group_list>
        <group group_id="B1">
          <title>High Flow Oxygen</title>
          <description>High Flow Oxygen were delivered between 20 and 70 L/min</description>
        </group>
        <group group_id="B2">
          <title>High Flow Air</title>
          <description>High Flow Air were delivered between 20 and 70 L/min</description>
        </group>
        <group group_id="B3">
          <title>Low Flow Oxygen</title>
          <description>Low Flow Oxygen were delivered at 2 L/min</description>
        </group>
        <group group_id="B4">
          <title>Low Flow Air</title>
          <description>Low Flow Air were delivered at 2 L/min</description>
        </group>
        <group group_id="B5">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="10"/>
            <count group_id="B2" value="11"/>
            <count group_id="B3" value="12"/>
            <count group_id="B4" value="11"/>
            <count group_id="B5" value="44"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="59" lower_limit="48" upper_limit="72"/>
                    <measurement group_id="B2" value="67" lower_limit="55" upper_limit="75"/>
                    <measurement group_id="B3" value="63" lower_limit="51" upper_limit="77"/>
                    <measurement group_id="B4" value="62" lower_limit="47" upper_limit="73"/>
                    <measurement group_id="B5" value="63" lower_limit="47" upper_limit="77"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="3"/>
                    <measurement group_id="B4" value="5"/>
                    <measurement group_id="B5" value="18"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="9"/>
                    <measurement group_id="B4" value="6"/>
                    <measurement group_id="B5" value="26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="2"/>
                    <measurement group_id="B5" value="4"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="11"/>
                    <measurement group_id="B4" value="9"/>
                    <measurement group_id="B5" value="40"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="1"/>
                    <measurement group_id="B5" value="5"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="11"/>
                    <measurement group_id="B4" value="10"/>
                    <measurement group_id="B5" value="38"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="12"/>
                    <measurement group_id="B4" value="11"/>
                    <measurement group_id="B5" value="44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Cancer Type</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Mesothelioma</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="2"/>
                    <measurement group_id="B4" value="3"/>
                    <measurement group_id="B5" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Non Small Cell Lung Cancer</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="7"/>
                    <measurement group_id="B4" value="5"/>
                    <measurement group_id="B5" value="28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Small Cell Lung Cancer</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="2"/>
                    <measurement group_id="B4" value="2"/>
                    <measurement group_id="B5" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="1"/>
                    <measurement group_id="B5" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Cancer Stage</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Localized</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="3"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Locally advanced</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="4"/>
                    <measurement group_id="B4" value="6"/>
                    <measurement group_id="B5" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Metastatic</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="5"/>
                    <measurement group_id="B4" value="5"/>
                    <measurement group_id="B5" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Comorbidities</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>COPD</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="2"/>
                    <measurement group_id="B4" value="1"/>
                    <measurement group_id="B5" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Heart Failure</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Asthma</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Modified Borg Scale Dyspnea Intensity at Isotime</title>
        <description>Assessed Dyspnea using the Modified Borg Scale Dyspnea Intensity that ranges from 0 (&quot;no shortness of breath&quot;) to 10 (&quot;worst possible shortness of breath&quot;) at Isotime. Measured the mean difference of Modified Borg Scale Dyspnea Intensity at isotime between the second exercise test (in which all patients received Low Flow Oxygen) and the third exercise tests (in which all patients received the assigned intervention).</description>
        <time_frame>End of second exercise test and end of third exercise test, approximately up to 12 minutes</time_frame>
        <population>The data is provided for 44 participants who completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>High Flow Oxygen</title>
            <description>High Flow Oxygen were delivered between 20 and 70 L/min</description>
          </group>
          <group group_id="O2">
            <title>High Flow Air</title>
            <description>High Flow Air were delivered between 20 and 70 L/min</description>
          </group>
          <group group_id="O3">
            <title>Low Flow Oxygen</title>
            <description>Low Flow Oxygen were delivered at 2 L/min</description>
          </group>
          <group group_id="O4">
            <title>Low Flow Air</title>
            <description>Low Flow Air were delivered at 2 L/min</description>
          </group>
        </group_list>
        <measure>
          <title>Modified Borg Scale Dyspnea Intensity at Isotime</title>
          <description>Assessed Dyspnea using the Modified Borg Scale Dyspnea Intensity that ranges from 0 (&quot;no shortness of breath&quot;) to 10 (&quot;worst possible shortness of breath&quot;) at Isotime. Measured the mean difference of Modified Borg Scale Dyspnea Intensity at isotime between the second exercise test (in which all patients received Low Flow Oxygen) and the third exercise tests (in which all patients received the assigned intervention).</description>
          <population>The data is provided for 44 participants who completed the study.</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="11"/>
                <count group_id="O3" value="12"/>
                <count group_id="O4" value="11"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.1" lower_limit="-2.1" upper_limit="-0.12"/>
                    <measurement group_id="O2" value="-0.2" lower_limit="-0.97" upper_limit="0.6"/>
                    <measurement group_id="O3" value="-1.8" lower_limit="-2.7" upper_limit="-0.9"/>
                    <measurement group_id="O4" value="-0.5" lower_limit="-1.3" upper_limit="0.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Slope of Modified Borg Scale Dyspnea Unpleasantness Over Time During Constant Work Exercise Per Minute (Third Test)</title>
        <description>Dyspnea unpleasantness was measured using the Modified Borg Scale Dyspnea Intensity that ranges from 0 (&quot;no shortness of breath&quot;) to 10 (&quot;worst possible shortness of breath&quot;). Dyspnea intensity was measured every minute. The number of minutes varied by patient, per test. It was measured as pairwise difference of slope (taking 'low flow air' arm as a reference). This linear mixed model was constructed based on the following: Dyspnea Unpleasantness at third test = Minutes + Study Arm + Study Arm*Minutes + Total work rate + Slope of Dyspnea Unpleasantness and Minutes at Second test + Minutes at second test.</description>
        <time_frame>Third exercise test, approximately up to 12 minutes</time_frame>
        <population>The data is provided for 44 participants who completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>High Flow Oxygen</title>
            <description>High Flow Oxygen were delivered between 20 and 70 L/min</description>
          </group>
          <group group_id="O2">
            <title>High Flow Air</title>
            <description>High Flow Air were delivered between 20 and 70 L/min</description>
          </group>
          <group group_id="O3">
            <title>Low Flow Oxygen</title>
            <description>Low Flow Oxygen were delivered at 2 L/min</description>
          </group>
          <group group_id="O4">
            <title>Low Flow Air</title>
            <description>Low Flow Air were delivered at 2 L/min</description>
          </group>
        </group_list>
        <measure>
          <title>Slope of Modified Borg Scale Dyspnea Unpleasantness Over Time During Constant Work Exercise Per Minute (Third Test)</title>
          <description>Dyspnea unpleasantness was measured using the Modified Borg Scale Dyspnea Intensity that ranges from 0 (&quot;no shortness of breath&quot;) to 10 (&quot;worst possible shortness of breath&quot;). Dyspnea intensity was measured every minute. The number of minutes varied by patient, per test. It was measured as pairwise difference of slope (taking 'low flow air' arm as a reference). This linear mixed model was constructed based on the following: Dyspnea Unpleasantness at third test = Minutes + Study Arm + Study Arm*Minutes + Total work rate + Slope of Dyspnea Unpleasantness and Minutes at Second test + Minutes at second test.</description>
          <population>The data is provided for 44 participants who completed the study.</population>
          <units>Units on a scale per minute</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="11"/>
                <count group_id="O3" value="12"/>
                <count group_id="O4" value="11"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.55" lower_limit="0.50" upper_limit="0.62"/>
                    <measurement group_id="O2" value="0.78" lower_limit="0.71" upper_limit="0.87"/>
                    <measurement group_id="O3" value="0.59" lower_limit="0.52" upper_limit="0.67"/>
                    <measurement group_id="O4" value="0.69" lower_limit="0.60" upper_limit="0.79"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Modified Borg Scale Leg Discomfort</title>
        <description>Leg discomfort was measured using the Modified Borg Scale Leg discomfort that ranges from 0 (&quot;no discomfort&quot;) to 10 (&quot;worst possible discomfort&quot;) during the constant work exercise of third test. Leg discomfort was measured every minute. The number of minutes varied by patient, per test. It was measured as pairwise difference of slope (taking 'low flow air' arm as a reference). This linear mixed model was constructed based on the following: Leg Discomfort at third test = Minutes + Study Arm + Study Arm*Minutes + Total work rate + Slope of Leg Discomfort and Minutes at Second test + Minutes at Second test.</description>
        <time_frame>Third exercise test, approximately up to 12 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>High Flow Oxygen</title>
            <description>High Flow Oxygen were delivered between 20 and 70 L/min</description>
          </group>
          <group group_id="O2">
            <title>High Flow Air</title>
            <description>High Flow Air were delivered between 20 and 70 L/min</description>
          </group>
          <group group_id="O3">
            <title>Low Flow Oxygen</title>
            <description>Low Flow Oxygen were delivered at 2 L/min</description>
          </group>
          <group group_id="O4">
            <title>Low Flow Air</title>
            <description>Low Flow Air were delivered at 2 L/min</description>
          </group>
        </group_list>
        <measure>
          <title>Modified Borg Scale Leg Discomfort</title>
          <description>Leg discomfort was measured using the Modified Borg Scale Leg discomfort that ranges from 0 (&quot;no discomfort&quot;) to 10 (&quot;worst possible discomfort&quot;) during the constant work exercise of third test. Leg discomfort was measured every minute. The number of minutes varied by patient, per test. It was measured as pairwise difference of slope (taking 'low flow air' arm as a reference). This linear mixed model was constructed based on the following: Leg Discomfort at third test = Minutes + Study Arm + Study Arm*Minutes + Total work rate + Slope of Leg Discomfort and Minutes at Second test + Minutes at Second test.</description>
          <units>Units on a scale per minute</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="11"/>
                <count group_id="O3" value="12"/>
                <count group_id="O4" value="11"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.59" lower_limit="0.53" upper_limit="0.64"/>
                    <measurement group_id="O2" value="0.91" lower_limit="0.82" upper_limit="0.99"/>
                    <measurement group_id="O3" value="0.65" lower_limit="0.58" upper_limit="0.74"/>
                    <measurement group_id="O4" value="0.81" lower_limit="0.71" upper_limit="0.91"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Exercise Endurance</title>
        <description>The Exercise endurance was measured as a mean duration of constant work in minutes during third test. It was measured as pairwise comparison of mean difference of exercise duration (taking 'low flow air' as a reference). This linear mixed model was constructed based on the following: Time at third test = Study Arm + Minutes at Second test. Detail output from the mixed models</description>
        <time_frame>End of third exercise test, approximately up to 12 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>High Flow Oxygen</title>
            <description>High Flow Oxygen were delivered between 20 and 70 L/min</description>
          </group>
          <group group_id="O2">
            <title>High Flow Air</title>
            <description>High Flow Air were delivered between 20 and 70 L/min</description>
          </group>
          <group group_id="O3">
            <title>Low Flow Oxygen</title>
            <description>Low Flow Oxygen were delivered at 2 L/min</description>
          </group>
          <group group_id="O4">
            <title>Low Flow Air</title>
            <description>Low Flow Air were delivered at 2 L/min</description>
          </group>
        </group_list>
        <measure>
          <title>Exercise Endurance</title>
          <description>The Exercise endurance was measured as a mean duration of constant work in minutes during third test. It was measured as pairwise comparison of mean difference of exercise duration (taking 'low flow air' as a reference). This linear mixed model was constructed based on the following: Time at third test = Study Arm + Minutes at Second test. Detail output from the mixed models</description>
          <units>minutes</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="11"/>
                <count group_id="O3" value="12"/>
                <count group_id="O4" value="11"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.50" lower_limit="7.48" upper_limit="13.52"/>
                    <measurement group_id="O2" value="8.18" lower_limit="7.03" upper_limit="9.34"/>
                    <measurement group_id="O3" value="7.58" lower_limit="6.0" upper_limit="9.17"/>
                    <measurement group_id="O4" value="7.36" lower_limit="6.35" upper_limit="8.37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Adverse Events</title>
        <description>Adverse effects related to supplemental oxygen use were assessed using a numeric rating scale from 0 (not at all) to 10 (worst possible) before and after the study intervention. The mean change was measured before and after the 3rd test ranging between -10 (improvement) and +10 (deterioration).</description>
        <time_frame>Before and after 3rd test during intervention phase, approximately up to 12 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>High Flow Oxygen</title>
            <description>High Flow Oxygen were delivered between 20 and 70 L/min</description>
          </group>
          <group group_id="O2">
            <title>High Flow Air</title>
            <description>High Flow Air were delivered between 20 and 70 L/min</description>
          </group>
          <group group_id="O3">
            <title>Low Flow Oxygen</title>
            <description>Low Flow Oxygen were delivered at 2 L/min</description>
          </group>
          <group group_id="O4">
            <title>Low Flow Air</title>
            <description>Low Flow Air were delivered at 2 L/min</description>
          </group>
        </group_list>
        <measure>
          <title>Adverse Events</title>
          <description>Adverse effects related to supplemental oxygen use were assessed using a numeric rating scale from 0 (not at all) to 10 (worst possible) before and after the study intervention. The mean change was measured before and after the 3rd test ranging between -10 (improvement) and +10 (deterioration).</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="11"/>
                <count group_id="O3" value="12"/>
                <count group_id="O4" value="11"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Dry eyes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" spread="0"/>
                    <measurement group_id="O2" value="0" spread="0"/>
                    <measurement group_id="O3" value="0.17" spread="0.94"/>
                    <measurement group_id="O4" value="0" spread="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Dry Nose</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" spread="0"/>
                    <measurement group_id="O2" value="-0.45" spread="1.21"/>
                    <measurement group_id="O3" value="-.033" spread="0.89"/>
                    <measurement group_id="O4" value="0.3" spread="0.67"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Eye Irritation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.1" spread="0.32"/>
                    <measurement group_id="O2" value="0" spread="0"/>
                    <measurement group_id="O3" value="0.33" spread="1.15"/>
                    <measurement group_id="O4" value="0" spread="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Moisture in nose</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1" spread="3.8"/>
                    <measurement group_id="O2" value="0.73" spread="1.56"/>
                    <measurement group_id="O3" value="0" spread="1.13"/>
                    <measurement group_id="O4" value="1.5" spread="2.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Nasal Prongs Uncomfortable</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.3" spread="0.67"/>
                    <measurement group_id="O2" value="0.18" spread="0.87"/>
                    <measurement group_id="O3" value="-0.17" spread="0.94"/>
                    <measurement group_id="O4" value="0.3" spread="0.67"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Suffocating</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.1" spread="1.2"/>
                    <measurement group_id="O2" value="-0.09" spread="0.54"/>
                    <measurement group_id="O3" value="0.08" spread="0.29"/>
                    <measurement group_id="O4" value="0.4" spread="0.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Anxious</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.4" spread="1.78"/>
                    <measurement group_id="O2" value="-0.55" spread="1.29"/>
                    <measurement group_id="O3" value="0.17" spread="0.72"/>
                    <measurement group_id="O4" value="0.5" spread="1.58"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Difficulty talking</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.1" spread="0.57"/>
                    <measurement group_id="O2" value="0.09" spread="0.3"/>
                    <measurement group_id="O3" value="0" spread="0"/>
                    <measurement group_id="O4" value="0" spread="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>before and after 3rd test during intervention phase, approximately up to 12 minutes</time_frame>
      <desc>In this protocol, the Adverse events were not measured as an absolute number. It was measured as a numeric rating score from 0 (not at all) to 10 (worst possible). So there are no Adverse events numbers in the Adverse Events section. As per the protocol, Adverse events were considered as a secondary outcome. Please see 'Adverse Events' under 'Outcome Measure.'</desc>
      <group_list>
        <group group_id="E1">
          <title>High Flow Oxygen</title>
          <description>High Flow Oxygen were delivered between 20 and 70 L/min</description>
        </group>
        <group group_id="E2">
          <title>High Flow Air</title>
          <description>High Flow Air were delivered between 20 and 70 L/min</description>
        </group>
        <group group_id="E3">
          <title>Low Flow Oxygen</title>
          <description>Low Flow Oxygen were delivered at 2 L/min</description>
        </group>
        <group group_id="E4">
          <title>Low Flow Air</title>
          <description>Low Flow Air were delivered at 2 L/min</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>David Hui, MD/ Associate Professor, Palliative Care Medicine</name_or_title>
      <organization>UT MD Anderson Cancer Center</organization>
      <phone>(713) 792-6258</phone>
      <email>dhui@mdanderson.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

